MassChallenge

Community
Industry
Short one liner description here
Short one liner description here
Short one liner description here
Short one liner description here
Short one liner description here
Short one liner description here
Short one liner description here
Short one liner description here
Short one liner description here
Short one liner description here
Accelerators
Founder-focused & industry
agnostic
Industry-specific for
mid-to-late stage startups
A variety of mentorship & industry
focuses for all stages
Driving innovation & startup
ecosystem development
Partnerships
Short one-liner description here
Short one-liner description here
Short one-liner description here
Short one-liner description here
About
Short one-liner description here
Short one-liner description here
Short one-liner description here
Short one-liner description here
Short one-liner description here
Short one-liner description here
Short one-liner description here

News

MassChallenge Switzerland Teams Up with Novonesis in Strategic Partnership

February 4th, 2025 (Renens, Switzerland) – MassChallenge Switzerland, part of MassChallenge’s global network of innovators, is excited to announce its partnership with Novonesis, leader in biosolutions, driving sustainability across Food & Beverages, Human Health, and Planetary Health.

Their innovative enzymes and microbial solutions enhance efficiency, reduce waste, and minimize environmental impact, promoting healthier lives and a greener planet. We will work together across many industries where biotechnology can have a positive impact, from energy and farming to ingredients and consumer goods.

“Novonesis are excited to partner with MassChallenge Switzerland. Our key focus on innovation and sustainability aligns with MassChallenge’s mission to drive change by identifying and accelerating leading startups. As the leading biosolutions company globally, Novonesis has unparalleled market access and strong capabilities to help scale industrial biotechnology processes across numerous industry verticals. To compliment our own innovation capabilities, partnership with leading startups is essential for our long-term success. MassChallenge offers strong capabilities to help support corporates such as Novonesis to identify promising startups and we are excited to join the other partners who contribute to making MassChallenge Switzerland unique.” Said Thomas Riis Jensen, Senior Director Ventures & External Innovation at Novonesis.

“MassChallenge Switzerland is delighted to bring Novonesis into our community. Novonesis has 100+ years of innovation and unprecedented capability in biosolutions spanning 30+ industries. This experience, combined with Novonesis’ desire to collaborate and leverage technology, makes them an excellent partner for the startups in our programs. We look forward to working closely with Novonesis to help bring startups solutions to market so people in society can enjoy a healthier life on a healthier planet,” said Matt Lashmar, Managing Director of MassChallenge Switzerland.

About Novonesis

Novonesis is a leading Danish multinational biotechnology company, born from the 2024 merger of Novozymes and Chr. Hansen. With a global workforce of around 10,000 employees, Novonesis stands at the forefront of innovation in enzymes and cultures. Its products serve a diverse range of industries, including carbon capture, bioenergy, animal health, and Food & Beverages. Driven by a commitment to microbiology and innovation, Novonesis aims to create a better world through the power of biology.

About MassChallenge

MassChallenge Switzerland is part of the MassChallenge global network for innovators. MassChallenge equips bold entrepreneurs to disrupt the status quo and create meaningful change. Since MassChallenge Switzerland’s launch in 2016, they have accelerated 950 startups who have raised over CHF2B in funding and generated over 59,000 Jobs.

🗓️ Applications for the 2025 Early-stage Accelerator Program are open now and close on March 5, 2025. Learn more and apply on MassChallenge Switzerland, and follow them on LinkedIn and X.